|
RU2573409C2
(ru)
|
2009-11-04 |
2016-01-20 |
Дзе Юниверсити Оф Бритиш Коламбиа |
Содержащие нуклеиновые кислоты липидные частицы и относящиеся к ним способы
|
|
US9006417B2
(en)
|
2010-06-30 |
2015-04-14 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
US10487332B2
(en)
|
2010-07-06 |
2019-11-26 |
Glaxosmithkline Biologicals Sa |
Immunisation of large mammals with low doses of RNA
|
|
FI4005592T3
(fi)
*
|
2010-07-06 |
2023-01-13 |
|
Virionin kaltaisia kuljetuspartikkeleita itsereplikoituville rna-molekyyleille
|
|
PT3243526T
(pt)
|
2010-07-06 |
2020-03-04 |
Glaxosmithkline Biologicals Sa |
Distribuição de arn para despoletar múltiplas vias imunitárias
|
|
CN103153284B
(zh)
|
2010-07-06 |
2015-11-25 |
诺华股份有限公司 |
含有其pKa值有利于RNA递送的脂质的脂质体
|
|
JP5911870B2
(ja)
|
2010-08-31 |
2016-04-27 |
ノバルティス アーゲー |
免疫原をコードするrnaの送達のためのpeg化リポソーム
|
|
KR102266691B1
(ko)
|
2010-10-11 |
2021-06-23 |
노파르티스 아게 |
항원 전달 플랫폼
|
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
JP2014522842A
(ja)
|
2011-07-06 |
2014-09-08 |
ノバルティス アーゲー |
免疫原性組み合わせ組成物およびその使用
|
|
RU2014104090A
(ru)
*
|
2011-07-06 |
2015-08-20 |
Новартис Аг |
Липосомы с эффективным соотношением n:p для доставки молекул phk
|
|
US20140328759A1
(en)
|
2011-10-25 |
2014-11-06 |
The University Of British Columbia |
Limit size lipid nanoparticles and related methods
|
|
CA2853689C
(en)
|
2011-11-04 |
2020-06-30 |
Nitto Denko Corporation |
Method of producing lipid nanoparticles for drug delivery
|
|
DE21212055T1
(de)
|
2011-12-07 |
2022-08-04 |
Alnylam Pharmaceuticals, Inc. |
Biologisch abbaubare lipide zur freisetzung von wirkstoffen
|
|
ES2923757T3
(es)
|
2011-12-16 |
2022-09-30 |
Modernatx Inc |
Composiciones de ARNm modificado
|
|
WO2013151664A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
CN114891871A
(zh)
|
2012-08-14 |
2022-08-12 |
10X基因组学有限公司 |
微胶囊组合物及方法
|
|
US10273541B2
(en)
|
2012-08-14 |
2019-04-30 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US10323279B2
(en)
|
2012-08-14 |
2019-06-18 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US10221442B2
(en)
|
2012-08-14 |
2019-03-05 |
10X Genomics, Inc. |
Compositions and methods for sample processing
|
|
US10584381B2
(en)
|
2012-08-14 |
2020-03-10 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US11591637B2
(en)
|
2012-08-14 |
2023-02-28 |
10X Genomics, Inc. |
Compositions and methods for sample processing
|
|
US9701998B2
(en)
|
2012-12-14 |
2017-07-11 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US9951386B2
(en)
|
2014-06-26 |
2018-04-24 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US10752949B2
(en)
|
2012-08-14 |
2020-08-25 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US10533221B2
(en)
|
2012-12-14 |
2020-01-14 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
EP3567116A1
(en)
|
2012-12-14 |
2019-11-13 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
KR20230003659A
(ko)
|
2013-02-08 |
2023-01-06 |
10엑스 제노믹스, 인크. |
폴리뉴클레오티드 바코드 생성
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
EP4279610A3
(en)
|
2013-03-15 |
2024-01-03 |
ModernaTX, Inc. |
Ribonucleic acid purification
|
|
CN105143456A
(zh)
*
|
2013-03-15 |
2015-12-09 |
不列颠哥伦比亚大学 |
用于转染的脂质纳米粒子和相关方法
|
|
WO2014144767A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
|
PT3670155T
(pt)
*
|
2013-06-13 |
2025-07-08 |
Aspect Biosystems Ltd |
Cabeça de impressão, sistema de fabrico aditivo de estruturas tridimensionais e respetivo método
|
|
PL3019619T3
(pl)
*
|
2013-07-11 |
2022-01-10 |
Modernatx, Inc. |
Kompozycje zawierające syntetyczne polinkleotydy kodujące białka powiązane z crispr i syntetyczne sgrna oraz sposoby ich stosowania
|
|
WO2015011633A1
(en)
*
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
|
CA2923029A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015048020A2
(en)
*
|
2013-09-24 |
2015-04-02 |
Alnylam Pharmaceuticals, Inc. |
Compositions and methods for the manufacture of lipid nanoparticles
|
|
EP3052511A4
(en)
|
2013-10-02 |
2017-05-31 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
US10159652B2
(en)
|
2013-10-16 |
2018-12-25 |
The University Of British Columbia |
Device for formulating particles at small volumes
|
|
US20150174549A1
(en)
*
|
2013-10-25 |
2015-06-25 |
The Brigham And Women's Hospital Corporation |
High-throughput synthesis of nanoparticles
|
|
SI3071696T1
(sl)
|
2013-11-22 |
2019-11-29 |
Mina Therapeutics Ltd |
C/EBP alfa kratko delujoči RNA sestavki in postopki uporabe
|
|
WO2015130584A2
(en)
*
|
2014-02-25 |
2015-09-03 |
Merck Sharp & Dohme Corp. |
Lipid nanoparticle vaccine adjuvants and antigen delivery systems
|
|
US9694361B2
(en)
|
2014-04-10 |
2017-07-04 |
10X Genomics, Inc. |
Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same
|
|
HRP20220070T1
(hr)
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
US10286086B2
(en)
|
2014-06-19 |
2019-05-14 |
Modernatx, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
CA2953341C
(en)
|
2014-06-25 |
2023-01-24 |
Acuitas Therapeutics Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
EP4574974A3
(en)
|
2014-06-26 |
2025-10-08 |
10x Genomics, Inc. |
Methods of analyzing nucleic acids from individual cells or cell populations
|
|
KR20170026383A
(ko)
|
2014-06-26 |
2017-03-08 |
10엑스 제노믹스, 인크. |
핵산 서열의 분석
|
|
US12312640B2
(en)
|
2014-06-26 |
2025-05-27 |
10X Genomics, Inc. |
Analysis of nucleic acid sequences
|
|
WO2016004318A1
(en)
*
|
2014-07-02 |
2016-01-07 |
Shire Human Genetic Therapies, Inc. |
Encapsulation of messenger rna
|
|
AU2015289656A1
(en)
|
2014-07-16 |
2017-02-16 |
Modernatx, Inc. |
Circular polynucleotides
|
|
WO2016011226A1
(en)
|
2014-07-16 |
2016-01-21 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
CN106794141B
(zh)
*
|
2014-07-16 |
2021-05-28 |
诺华股份有限公司 |
将核酸包封在脂质纳米粒主体中的方法
|
|
EP3171895A1
(en)
|
2014-07-23 |
2017-05-31 |
Modernatx, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
WO2016045732A1
(en)
*
|
2014-09-25 |
2016-03-31 |
Biontech Rna Pharmaceuticals Gmbh |
Stable formulations of lipids and liposomes
|
|
JP2017532042A
(ja)
|
2014-10-29 |
2017-11-02 |
10エックス ゲノミクス,インコーポレイテッド |
標的化核酸配列決定のための方法及び組成物
|
|
US9975122B2
(en)
|
2014-11-05 |
2018-05-22 |
10X Genomics, Inc. |
Instrument systems for integrated sample processing
|
|
US11045488B2
(en)
|
2014-12-26 |
2021-06-29 |
Nitto Denko Corporation |
RNA interference agents for GST-π gene modulation
|
|
US10264976B2
(en)
*
|
2014-12-26 |
2019-04-23 |
The University Of Akron |
Biocompatible flavonoid compounds for organelle and cell imaging
|
|
AU2016207023B2
(en)
|
2015-01-12 |
2019-12-05 |
10X Genomics, Inc. |
Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same
|
|
EP3247328B1
(en)
*
|
2015-01-21 |
2026-01-07 |
Genevant Sciences Gmbh |
Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
|
|
EP4286516A3
(en)
|
2015-02-24 |
2024-03-06 |
10X Genomics, Inc. |
Partition processing methods and systems
|
|
WO2016138175A1
(en)
*
|
2015-02-24 |
2016-09-01 |
The University Of British Columbia |
Continuous flow microfluidic system
|
|
AU2016222719B2
(en)
|
2015-02-24 |
2022-03-31 |
10X Genomics, Inc. |
Methods for targeted nucleic acid sequence coverage
|
|
WO2016153012A1
(ja)
|
2015-03-24 |
2016-09-29 |
協和発酵キリン株式会社 |
核酸含有脂質ナノ粒子
|
|
EP4353257A3
(en)
|
2015-04-13 |
2024-08-07 |
CureVac Manufacturing GmbH |
Method for producing rna compositions
|
|
WO2016176330A1
(en)
|
2015-04-27 |
2016-11-03 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
CN107921381B
(zh)
|
2015-04-28 |
2021-11-09 |
不列颠哥伦比亚大学 |
一次性微流控盒
|
|
HUE067372T2
(hu)
|
2015-06-29 |
2024-10-28 |
Acuitas Therapeutics Inc |
Lipidek és nanoszemcsés lipid formulázások nukleinsavak beadására
|
|
EP3328394A4
(en)
|
2015-07-30 |
2019-03-13 |
ModernaTX, Inc. |
CONCATEMEE peptide epitope RNAs
|
|
WO2017031232A1
(en)
|
2015-08-17 |
2017-02-23 |
Modernatx, Inc. |
Methods for preparing particles and related compositions
|
|
WO2017049286A1
(en)
|
2015-09-17 |
2017-03-23 |
Moderna Therapeutics, Inc. |
Polynucleotides containing a morpholino linker
|
|
EP4101930A1
(en)
|
2015-09-17 |
2022-12-14 |
ModernaTX, Inc. |
Polynucleotides containing a stabilizing tail region
|
|
US20180312873A1
(en)
*
|
2015-10-20 |
2018-11-01 |
10X Genomics, Inc. |
Method and systems for high throughput single cell genetic manipulation
|
|
MA46023A
(fr)
|
2015-10-22 |
2019-07-03 |
Modernatx Inc |
Vaccin contre le virus de la grippe à large spectre
|
|
US20180271970A1
(en)
|
2015-10-22 |
2018-09-27 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
EP3364949A4
(en)
|
2015-10-22 |
2019-07-31 |
ModernaTX, Inc. |
CANCER VACCINES
|
|
DE20164728T1
(de)
|
2015-10-22 |
2021-09-30 |
Modernatx, Inc. |
Impfstoffe gegen atemwegsvirus
|
|
EP3364981A4
(en)
|
2015-10-22 |
2019-08-07 |
ModernaTX, Inc. |
VACCINE AGAINST THE HUMAN CYTOMEGALOVIRUS
|
|
SG11201803360UA
(en)
|
2015-10-22 |
2018-05-30 |
Modernatx Inc |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
PE20181531A1
(es)
|
2015-10-22 |
2018-09-26 |
Modernatx Inc |
Vacuna del virus herpes simple
|
|
CN108368028B
(zh)
|
2015-10-28 |
2021-09-03 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
|
WO2018081480A1
(en)
|
2016-10-26 |
2018-05-03 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
|
KR102723865B1
(ko)
|
2015-12-04 |
2024-10-29 |
10엑스 제노믹스, 인크. |
핵산 분석을 위한 방법 및 조성물
|
|
WO2017106799A1
(en)
*
|
2015-12-17 |
2017-06-22 |
Modernatx, Inc. |
POLYNUCLEOTIDES ENCODING METHYLMALONYL-CoA MUTASE
|
|
SMT202200310T1
(it)
|
2015-12-23 |
2022-09-14 |
Modernatx Inc |
Metodi di utilizzo dei polinucleotidi codificanti il ligando di ox40
|
|
US12678515B2
(en)
|
2015-12-30 |
2026-07-14 |
Acuitas Therapeutics, Inc. |
Lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
WO2017117647A1
(en)
|
2016-01-06 |
2017-07-13 |
The University Of British Columbia |
Bifurcating mixers and methods of their use and manufacture
|
|
US20190241658A1
(en)
|
2016-01-10 |
2019-08-08 |
Modernatx, Inc. |
Therapeutic mRNAs encoding anti CTLA-4 antibodies
|
|
CN105622473B
(zh)
*
|
2016-02-06 |
2017-07-25 |
吴国球 |
一种阳离子氨基脂质及其合成方法和用途
|
|
WO2017197343A2
(en)
|
2016-05-12 |
2017-11-16 |
10X Genomics, Inc. |
Microfluidic on-chip filters
|
|
WO2017197338A1
(en)
|
2016-05-13 |
2017-11-16 |
10X Genomics, Inc. |
Microfluidic systems and methods of use
|
|
PL3458074T3
(pl)
*
|
2016-05-16 |
2024-11-12 |
Board Of Regents Of The University Of Texas System |
KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA
|
|
CN115837014A
(zh)
*
|
2016-05-18 |
2023-03-24 |
摩登纳特斯有限公司 |
编码松弛素的多核苷酸
|
|
CN107441506A
(zh)
*
|
2016-05-30 |
2017-12-08 |
上海交通大学 |
基因输送载体及其制备与应用
|
|
US11059039B2
(en)
|
2016-07-06 |
2021-07-13 |
Precision Nanosystems Inc. |
Smart microfluidic mixing instrument and cartridges
|
|
WO2018064755A1
(en)
|
2016-10-03 |
2018-04-12 |
Precision Nanosystems Inc. |
Compositions for transfecting resistant cell types
|
|
KR20190093816A
(ko)
|
2016-10-26 |
2019-08-26 |
큐어백 아게 |
지질 나노입자 mRNA 백신
|
|
US12491261B2
(en)
|
2016-10-26 |
2025-12-09 |
Acuitas Therapeutics, Inc. |
Lipid nanoparticle formulations
|
|
WO2018081638A1
(en)
|
2016-10-27 |
2018-05-03 |
The Trustees Of The University Of Pennsylvania |
Nucleoside-modified rna for inducing an adaptive immune response
|
|
MA46766A
(fr)
|
2016-11-11 |
2019-09-18 |
Modernatx Inc |
Vaccin antigrippal
|
|
CA3046977A1
(en)
|
2016-12-16 |
2018-06-21 |
Delphi Scientific, Llc |
Layered particles and processes thereof
|
|
US10550429B2
(en)
|
2016-12-22 |
2020-02-04 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US10815525B2
(en)
|
2016-12-22 |
2020-10-27 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
US10011872B1
(en)
|
2016-12-22 |
2018-07-03 |
10X Genomics, Inc. |
Methods and systems for processing polynucleotides
|
|
EP3568155A4
(en)
|
2017-01-11 |
2020-09-23 |
The Trustees Of The University Of Pennsylvania |
RNA MODIFIED BY NUCLEOSIDE TO INDUCE AN IMMUNE RESPONSE AGAINST ZIKA VIRUS
|
|
US12264411B2
(en)
|
2017-01-30 |
2025-04-01 |
10X Genomics, Inc. |
Methods and systems for analysis
|
|
EP4310183B1
(en)
|
2017-01-30 |
2025-07-09 |
10X Genomics, Inc. |
Methods and systems for droplet-based single cell barcoding
|
|
EP3595872A4
(en)
|
2017-03-15 |
2021-05-05 |
Aspect Biosystems Ltd. |
SYSTEMS AND METHODS FOR PRINTING A FIBROUS STRUCTURE
|
|
US11576961B2
(en)
|
2017-03-15 |
2023-02-14 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
WO2018170260A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Respiratory syncytial virus vaccine
|
|
WO2018170347A1
(en)
|
2017-03-17 |
2018-09-20 |
Modernatx, Inc. |
Zoonotic disease rna vaccines
|
|
MA48047A
(fr)
|
2017-04-05 |
2020-02-12 |
Modernatx Inc |
Réduction ou élimination de réponses immunitaires à des protéines thérapeutiques administrées par voie non intraveineuse, par exemple par voie sous-cutanée
|
|
US12269001B2
(en)
*
|
2017-04-13 |
2025-04-08 |
National University Corporation Hokkaido University |
Flow channel structure and lipid particle or micelle formation method using same
|
|
US11357856B2
(en)
|
2017-04-13 |
2022-06-14 |
Acuitas Therapeutics, Inc. |
Lipids for delivery of active agents
|
|
WO2018191719A1
(en)
|
2017-04-13 |
2018-10-18 |
Acuitas Therapeutics, Inc. |
Lipid delivery of therapeutic agents to adipose tissue
|
|
US11596679B2
(en)
|
2017-04-27 |
2023-03-07 |
Vanderbilt University |
Hepatitis C virus gene sequences and methods of use therefor
|
|
US11820728B2
(en)
|
2017-04-28 |
2023-11-21 |
Acuitas Therapeutics, Inc. |
Carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
|
AU2018270111B2
(en)
|
2017-05-18 |
2022-07-14 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
|
|
EP4253544A3
(en)
|
2017-05-18 |
2023-12-20 |
ModernaTX, Inc. |
Modified messenger rna comprising functional rna elements
|
|
CN116064732A
(zh)
|
2017-05-26 |
2023-05-05 |
10X基因组学有限公司 |
转座酶可接近性染色质的单细胞分析
|
|
US10844372B2
(en)
|
2017-05-26 |
2020-11-24 |
10X Genomics, Inc. |
Single cell analysis of transposase accessible chromatin
|
|
BR112019025104A2
(pt)
*
|
2017-05-30 |
2020-06-23 |
Glaxosmithkline Biologicals S.A. |
Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
MA49421A
(fr)
|
2017-06-15 |
2020-04-22 |
Modernatx Inc |
Formulations d'arn
|
|
JP7355731B2
(ja)
|
2017-08-16 |
2023-10-03 |
アクイタス セラピューティクス インコーポレイテッド |
脂質ナノ粒子製剤における使用のための脂質
|
|
US11524932B2
(en)
|
2017-08-17 |
2022-12-13 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
CA3073161A1
(en)
|
2017-08-17 |
2019-02-21 |
The Trustees Of The University Of Pennsylvania |
Modified mrna vaccines encoding herpes simplex virus glycoproteins and uses thereof
|
|
JP7461872B2
(ja)
|
2017-08-17 |
2024-04-04 |
アクイタス セラピューティクス インコーポレイテッド |
脂質ナノ粒子製剤における使用のための脂質
|
|
WO2019036028A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
|
|
MX2020002348A
(es)
|
2017-08-31 |
2020-10-08 |
Modernatx Inc |
Métodos de elaboración de nanopartículas lipídicas.
|
|
WO2019048632A1
(en)
|
2017-09-08 |
2019-03-14 |
Mina Therapeutics Limited |
STABILIZED COMPOSITIONS OF SMALL ACTIVATORY RNA (PARNA) OF HNF4A AND METHODS OF USE
|
|
WO2019048645A1
(en)
|
2017-09-08 |
2019-03-14 |
Mina Therapeutics Limited |
STABILIZED COMPOSITIONS OF SMALL ACTIVATOR RNA (PARNA) FROM CEBPA AND METHODS OF USE
|
|
HRP20260181T1
(hr)
*
|
2017-10-20 |
2026-03-27 |
BioNTech SE |
Priprema i skladištenje lipozomskih rnk formulacija koje su pogodne za terapiju
|
|
WO2019089828A1
(en)
|
2017-10-31 |
2019-05-09 |
Acuitas Therapeutics, Inc. |
Lamellar lipid nanoparticles
|
|
CN111565833B
(zh)
|
2017-11-01 |
2023-04-07 |
国立大学法人大阪大学 |
用于制造具有期望的粒径的脂质颗粒的方法及装置的开发
|
|
EP3625361A1
(en)
|
2017-11-15 |
2020-03-25 |
10X Genomics, Inc. |
Functionalized gel beads
|
|
WO2019099908A1
(en)
|
2017-11-17 |
2019-05-23 |
10X Genomics, Inc. |
Methods and systems for associating physical and genetic properties of biological particles
|
|
EP3714048B1
(en)
|
2017-11-22 |
2025-04-09 |
ModernaTX, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
JP7424976B2
(ja)
|
2017-11-22 |
2024-01-30 |
モダーナティエックス・インコーポレイテッド |
プロピオン酸血症の治療用のプロピオニルCoAカルボキシラーゼアルファ及びベータサブユニットをコードするポリヌクレオチド
|
|
US11939601B2
(en)
|
2017-11-22 |
2024-03-26 |
Modernatx, Inc. |
Polynucleotides encoding phenylalanine hydroxylase for the treatment of phenylketonuria
|
|
CN111542338B
(zh)
*
|
2017-12-27 |
2024-06-18 |
武田药品工业株式会社 |
含核酸脂质纳米粒子及其用途
|
|
CA3086885A1
(en)
|
2017-12-28 |
2019-07-04 |
Kyoto University |
Composition for modifying target gene
|
|
TWI802627B
(zh)
|
2017-12-28 |
2023-05-21 |
日商武田藥品工業股份有限公司 |
陽離子性脂質
|
|
US11802146B2
(en)
|
2018-01-05 |
2023-10-31 |
Modernatx, Inc. |
Polynucleotides encoding anti-chikungunya virus antibodies
|
|
CN111971066B
(zh)
*
|
2018-01-18 |
2025-03-11 |
伊泽阿恩埃免疫疗法股份有限公司 |
脂质纳米颗粒
|
|
US11911453B2
(en)
|
2018-01-29 |
2024-02-27 |
Modernatx, Inc. |
RSV RNA vaccines
|
|
WO2019152672A1
(en)
*
|
2018-01-31 |
2019-08-08 |
Prolynx Llc |
Aseptic method and apparatus to prepare sterile formulations of drug-linked hydrogel microspheres
|
|
EP3775271B1
(en)
|
2018-04-06 |
2025-03-12 |
10X Genomics, Inc. |
Systems and methods for quality control in single cell processing
|
|
US20210163928A1
(en)
|
2018-04-11 |
2021-06-03 |
Modernatx, Inc. |
Messenger rna comprising functional rna elements
|
|
US11566246B2
(en)
|
2018-04-12 |
2023-01-31 |
Mina Therapeutics Limited |
SIRT1-saRNA compositions and methods of use
|
|
ES3001512T3
(en)
|
2018-04-29 |
2025-03-05 |
Global Life Sciences Solutions Canada Ulc |
Compositions for transfecting resistant cell types
|
|
MA52709A
(fr)
|
2018-05-23 |
2021-03-31 |
Modernatx Inc |
Administration d'adn
|
|
US20210261964A1
(en)
*
|
2018-07-19 |
2021-08-26 |
The Research Foundation For Microbial Diseases Of Osaka University |
LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE
|
|
WO2020023390A1
(en)
|
2018-07-25 |
2020-01-30 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
EP3608426A1
(en)
|
2018-08-10 |
2020-02-12 |
Pantherna Therapeutics GmbH |
Recombinant nucleic acid construct
|
|
DK3833786T5
(da)
|
2018-08-10 |
2024-08-19 |
Pantherna Therapeutics Gmbh |
Rekombinant nucleinsyrekonstrukt
|
|
MA53545A
(fr)
|
2018-09-02 |
2021-07-14 |
Modernatx Inc |
Polynucléotides codant pour l'acyl-coa déshydrogénase à très longue chaîne pour le traitement de l'insuffisance en acyl-coa déshydrogénase à très longue chaîne
|
|
JP2022500436A
(ja)
|
2018-09-13 |
2022-01-04 |
モダーナティエックス・インコーポレイテッドModernaTX, Inc. |
糖原病を処置するためのグルコース−6−ホスファターゼをコードするポリヌクレオチド
|
|
US12644102B2
(en)
|
2018-09-13 |
2026-06-02 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex E1-α, E1-β, and E2 subunits for the treatment of maple syrup urine disease
|
|
MA53615A
(fr)
|
2018-09-14 |
2021-07-21 |
Modernatx Inc |
Polynucléotides codant pour le polypeptide a1, de la famille de l'uridine diphosphate glycosyltransférase 1, pour le traitement du syndrome de crigler-najjar
|
|
CN112996854B
(zh)
|
2018-09-19 |
2024-08-30 |
摩登纳特斯有限公司 |
高纯度peg脂质和其用途
|
|
EP3853003B1
(en)
|
2018-09-19 |
2026-07-22 |
Aspect Biosystems Ltd. |
Systems and methods for printing a core fiber
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
EP3852911B1
(en)
|
2018-09-21 |
2025-01-22 |
Acuitas Therapeutics, Inc. |
Systems and methods for manufacturing lipid nanoparticles and liposomes
|
|
WO2020069169A1
(en)
|
2018-09-27 |
2020-04-02 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
US20210322575A1
(en)
|
2018-09-28 |
2021-10-21 |
Nutcracker Therapeutics, Inc. |
Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
|
|
DK3864163T3
(da)
|
2018-10-09 |
2024-05-06 |
Univ British Columbia |
Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed
|
|
CA3116576A1
(en)
|
2018-10-18 |
2020-04-23 |
Acuitas Therapeutics, Inc. |
Lipids for lipid nanoparticle delivery of active agents
|
|
CA3115751A1
(en)
*
|
2018-10-18 |
2020-04-23 |
Takeda Pharmaceutical Company Limited |
Method for activation/proliferation of t cells
|
|
US20220001026A1
(en)
|
2018-11-08 |
2022-01-06 |
Modernatx, Inc. |
Use of mrna encoding ox40l to treat cancer in human patients
|
|
JPWO2020095927A1
(ja)
*
|
2018-11-09 |
2021-10-14 |
国立大学法人北海道大学 |
粒子含有水溶液の製造方法
|
|
EP3886901A1
(en)
|
2018-11-29 |
2021-10-06 |
GlaxoSmithKline Biologicals S.A. |
Methods for manufacturing an adjuvant
|
|
PL3908568T3
(pl)
|
2019-01-11 |
2024-12-02 |
Acuitas Therapeutics, Inc. |
Lipidy do dostarczania środków czynnych w nanocząstkach lipidowych
|
|
CN113939282A
(zh)
|
2019-01-31 |
2022-01-14 |
摩登纳特斯有限公司 |
制备脂质纳米颗粒的方法
|
|
EP3953473A1
(en)
|
2019-04-12 |
2022-02-16 |
MiNA Therapeutics Limited |
Sirt1-sarna compositions and methods of use
|
|
WO2020227642A1
(en)
|
2019-05-08 |
2020-11-12 |
Modernatx, Inc. |
Compositions for skin and wounds and methods of use thereof
|
|
JP7416096B2
(ja)
|
2019-06-20 |
2024-01-17 |
プレシジョン ナノシステムズ ユーエルシー |
核酸送達のためのイオン化可能な脂質
|
|
MA56517A
(fr)
|
2019-06-24 |
2022-04-27 |
Modernatx Inc |
Arn messager comprenant des éléments d'arn fonctionnels et leurs utilisations
|
|
EP3987027A1
(en)
|
2019-06-24 |
2022-04-27 |
ModernaTX, Inc. |
Endonuclease-resistant messenger rna and uses thereof
|
|
KR102928289B1
(ko)
|
2019-06-29 |
2026-02-20 |
글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 |
핵산 전달을 위한 이온화 가능한 지질
|
|
EP4010481A4
(en)
*
|
2019-08-09 |
2023-09-20 |
Nutcracker Therapeutics, Inc. |
MICROFLUIDIC DEVICE AND METHODS OF USE
|
|
GB2600859B
(en)
|
2019-08-14 |
2024-04-03 |
Acuitas Therapeutics Inc |
Improved lipid nanoparticles for delivery of nucleic acids
|
|
WO2021038508A1
(en)
|
2019-08-30 |
2021-03-04 |
Glaxosmithkline Biologicals Sa |
Jet mixing lipid nanoparticle manufacturing process
|
|
WO2021061594A1
(en)
*
|
2019-09-27 |
2021-04-01 |
Merck Sharp & Dohme Corp. |
Method for measuring nucleic acid content in lipid nanoprticles using ultraviolet spectrometry
|
|
CN114502269A
(zh)
*
|
2019-10-04 |
2022-05-13 |
国立大学法人北海道大学 |
三维流路结构体及使用其的纳米粒子的制造方法
|
|
CN115778904B
(zh)
*
|
2019-10-29 |
2025-03-28 |
珠海丽凡达生物技术有限公司 |
一种用于体外转染和体内递送mRNA的制剂
|
|
US12378560B2
(en)
|
2019-10-29 |
2025-08-05 |
Northwestern University |
Sequence multiplicity within spherical nucleic acids
|
|
EP4051487A4
(en)
|
2019-11-01 |
2023-11-22 |
Aspect Biosystems Ltd. |
SYSTEMS AND METHODS FOR PRINTING A CORE-SHELL FIBER
|
|
EP3838266A1
(en)
*
|
2019-12-20 |
2021-06-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Microfluidic production of biofunctionalized giant unilamellar vesicles for targeted intracellular cargo delivery
|
|
CN110974954B
(zh)
*
|
2019-12-24 |
2021-03-16 |
珠海丽凡达生物技术有限公司 |
一种用于增强核酸疫苗免疫效果的脂质纳米颗粒及其制备方法
|
|
US12194089B2
(en)
|
2020-02-04 |
2025-01-14 |
CureVac SE |
Coronavirus vaccine
|
|
EP3865579A1
(en)
|
2020-02-12 |
2021-08-18 |
Pantherna Therapeutics GmbH |
Recombinant nucleic acid construct and use thereof
|
|
IL294771A
(en)
|
2020-02-11 |
2022-09-01 |
Pantherna Therapeutics Gmbh |
Recombinant nucleic acid construct and use thereof
|
|
CN111281981B
(zh)
*
|
2020-02-19 |
2020-12-11 |
深圳厚存纳米药业有限公司 |
泊洛沙姆和/或泊洛沙胺与peg脂质组合的复合物纳米粒
|
|
CA3174708A1
(en)
*
|
2020-03-04 |
2021-09-10 |
Verve Therapeutics, Inc. |
Compositions and methods for targeted rna delivery
|
|
CA3178344A1
(en)
|
2020-03-31 |
2021-10-07 |
The Trustees Of The University Of Pennsylvania |
Universal influenza vaccine using nucleoside-modified mrna
|
|
AU2021252164B2
(en)
|
2020-04-09 |
2026-07-02 |
Finncure Oy |
Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses
|
|
EP4132951A4
(en)
|
2020-04-09 |
2025-06-11 |
Verve Therapeutics, Inc. |
CHEMICALLY MODIFIED GENE EDITING GUIDE RNAS WITH CAS12B
|
|
US12194157B2
(en)
|
2020-04-09 |
2025-01-14 |
Finncure Oy |
Carrier for targeted delivery to a host
|
|
AU2021285812A1
(en)
|
2020-06-01 |
2023-01-05 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
EP4178544A4
(en)
|
2020-07-08 |
2024-09-25 |
The Trustees of the University of Pennsylvania |
NUCLEOSIDE-MODIFIED RNA TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV-2 VIRUS
|
|
KR20230051172A
(ko)
|
2020-07-16 |
2023-04-17 |
아퀴타스 테라퓨틱스 인크. |
지질 나노 입자에 사용하기 위한 양이온성 지질
|
|
US11406703B2
(en)
|
2020-08-25 |
2022-08-09 |
Modernatx, Inc. |
Human cytomegalovirus vaccine
|
|
CZ310613B6
(cs)
|
2020-09-23 |
2026-01-28 |
Ústav organické chemie a biochemie AV ČR, v. v. i. |
Lipidoidy pro transfekci nukleových kyselin a jejich použití
|
|
US12678406B2
(en)
|
2020-10-12 |
2026-07-14 |
Translate Bio Inc. |
Process of preparing ice-based lipid nanoparticles
|
|
MX2023004299A
(es)
|
2020-10-13 |
2023-07-07 |
Univ Pennsylvania |
Direccionamiento de células t cd4+ in vivo para terapeuticos de arnm.
|
|
MX2023004371A
(es)
|
2020-10-14 |
2023-07-26 |
George Mason Res Foundation Inc |
Lípidos ionizables, y métodos de fabricación y uso de los mismos.
|
|
CN116710074A
(zh)
*
|
2020-10-14 |
2023-09-05 |
乔治梅森研究基金会公司 |
脂质纳米颗粒制造方法和由其衍生的组合物
|
|
CN112251222B
(zh)
*
|
2020-10-29 |
2022-03-08 |
东南大学 |
一种脂滴诱导及成像试剂及其制备方法和应用
|
|
WO2022099003A1
(en)
|
2020-11-06 |
2022-05-12 |
Sanofi |
Lipid nanoparticles for delivering mrna vaccines
|
|
CA3199784A1
(en)
|
2020-11-13 |
2022-05-19 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
DE102020214601A1
(de)
*
|
2020-11-19 |
2022-05-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung eingetragener Verein |
Verfahren und Vorrichtung zur Herstellung einer Flüssigkeit enthaltend Liposomen und hergestellte Flüssigkeit
|
|
CN117098541A
(zh)
|
2020-11-25 |
2023-11-21 |
阿卡格拉医药公司 |
用于递送核酸的脂质纳米粒及相关使用方法
|
|
US20240100492A1
(en)
|
2020-11-30 |
2024-03-28 |
Andre Wild |
Non aggregating microfluidic mixer and methods therefor
|
|
GB2603454A
(en)
|
2020-12-09 |
2022-08-10 |
Ucl Business Ltd |
Novel therapeutics for the treatment of neurodegenerative disorders
|
|
MX2023007574A
(es)
|
2020-12-22 |
2023-09-29 |
CureVac SE |
"vacuna de arn contra variantes de sars-cov-2.
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
EP4304640A1
(en)
|
2021-03-12 |
2024-01-17 |
Northwestern University |
Antiviral vaccines using spherical nucleic acids
|
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
US20240189449A1
(en)
|
2021-03-24 |
2024-06-13 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
WO2022204380A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
US20240207374A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
WO2022204390A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
US20240175033A1
(en)
|
2021-03-26 |
2024-05-30 |
Mina Therapeutics Limited |
TMEM173 saRNA Compositions and Methods of Use
|
|
EP4319803B1
(en)
|
2021-04-08 |
2025-11-26 |
Vaxthera SAS |
Coronavirus vaccine comprising a mosaic protein
|
|
CN117015511A
(zh)
*
|
2021-04-22 |
2023-11-07 |
创技公司株式会社 |
脂质纳米颗粒的制备方法及其制备装置
|
|
US20240165044A1
(en)
*
|
2021-04-22 |
2024-05-23 |
Inventage Lab Inc. |
Lipid nanoparticle preparation method and preparation apparatus therefor
|
|
EP4329734A4
(en)
|
2021-04-26 |
2025-04-02 |
Celanese EVA Performance Polymers LLC |
Implantable device for the delayed release of a macromolecular drug compound
|
|
WO2022240193A1
(ko)
*
|
2021-05-11 |
2022-11-17 |
(주)인벤티지랩 |
지질 나노 입자 제조용 칩, 이를 포함하는 지질 나노 입자 제조 시스템 및 지질 나노 입자 제조 방법
|
|
WO2022240806A1
(en)
|
2021-05-11 |
2022-11-17 |
Modernatx, Inc. |
Non-viral delivery of dna for prolonged polypeptide expression in vivo
|
|
US20240384277A1
(en)
|
2021-06-15 |
2024-11-21 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
US20240376445A1
(en)
|
2021-06-22 |
2024-11-14 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
CZ310443B6
(cs)
|
2021-07-19 |
2025-06-25 |
Ústav organické chemie a biochemie AV ČR, v. v. i. |
Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití
|
|
WO2023009421A1
(en)
*
|
2021-07-26 |
2023-02-02 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticle compositions
|
|
EP4380576A4
(en)
|
2021-08-03 |
2026-04-29 |
Verve Therapeutics Inc |
RNA TARGETED COMPOSITIONS AND ADMINISTRATION METHODS
|
|
CN113842960B
(zh)
*
|
2021-08-10 |
2023-07-21 |
华东师范大学 |
一种利用新型微流控装置制备核酸脂质纳米粒的方法
|
|
EP4387659A4
(en)
|
2021-08-18 |
2025-09-03 |
Univ Pennsylvania |
MRNA VACCINES DIRECTED AGAINST TICK SALIVARY PROTEINS AND METHODS OF USE THEREOF
|
|
JP2024535004A
(ja)
|
2021-09-10 |
2024-09-26 |
浙江吉量科技有限公司 |
イオン化可能な脂質その調製および遺伝子送達における使用
|
|
EP4398882A1
(en)
*
|
2021-09-10 |
2024-07-17 |
BioNTech SE |
Lipid-based rna formulations suitable for therapy
|
|
US20250017867A1
(en)
|
2021-10-01 |
2025-01-16 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
WO2023081546A1
(en)
*
|
2021-11-05 |
2023-05-11 |
Verily Life Sciences Llc |
Methods and systems for point-of-care synthesis and administration of particle-based therapeutics
|
|
WO2023081526A1
(en)
|
2021-11-08 |
2023-05-11 |
Orna Therapeutics, Inc. |
Lipid nanoparticle compositions for delivering circular polynucleotides
|
|
WO2023099884A1
(en)
|
2021-12-01 |
2023-06-08 |
Mina Therapeutics Limited |
Pax6 sarna compositions and methods of use
|
|
GB202117758D0
(en)
|
2021-12-09 |
2022-01-26 |
Ucl Business Ltd |
Therapeutics for the treatment of neurodegenerative disorders
|
|
WO2023114943A2
(en)
|
2021-12-16 |
2023-06-22 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
|
CN114247398A
(zh)
*
|
2021-12-17 |
2022-03-29 |
沈磊 |
一种脂质纳米颗粒制备系统及设备
|
|
JP7888167B2
(ja)
*
|
2022-02-08 |
2026-07-13 |
国立大学法人北海道大学 |
流路構造体およびこれを用いた自己組織化物質粒子の製造方法
|
|
US20250327041A1
(en)
|
2022-02-24 |
2025-10-23 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
WO2023170435A1
(en)
|
2022-03-07 |
2023-09-14 |
Mina Therapeutics Limited |
Il10 sarna compositions and methods of use
|
|
WO2023177904A1
(en)
|
2022-03-18 |
2023-09-21 |
Modernatx, Inc. |
Sterile filtration of lipid nanoparticles and filtration analysis thereof for biological applications
|
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
WO2023196399A1
(en)
|
2022-04-06 |
2023-10-12 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding argininosuccinate lyase for the treatment of argininosuccinic aciduria
|
|
US20250288659A1
(en)
|
2022-04-27 |
2025-09-18 |
Shanghai Regenelead Therapies Co., Ltd. |
Nucleic acid construct and use thereof
|
|
US20250319035A1
(en)
*
|
2022-04-30 |
2025-10-16 |
Shuwen TONG |
Cationic lipid nanoparticle having high transfection efficiency and preparation method therefor
|
|
WO2023215498A2
(en)
|
2022-05-05 |
2023-11-09 |
Modernatx, Inc. |
Compositions and methods for cd28 antagonism
|
|
TW202400784A
(zh)
|
2022-05-13 |
2024-01-01 |
大陸商上海瑞宏迪醫藥有限公司 |
包含utr的核酸構建體及其應用
|
|
WO2023230587A2
(en)
*
|
2022-05-25 |
2023-11-30 |
Akagera Medicines, Inc. |
Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
|
|
WO2024006863A1
(en)
|
2022-06-30 |
2024-01-04 |
Precision NanoSystems ULC |
Lipid nanoparticle formulations for vaccines
|
|
TWI858802B
(zh)
*
|
2022-07-06 |
2024-10-11 |
南韓商綠十字股份有限公司 |
使用陽離子膽固醇用於核酸遞送的局部遞送的脂質納米顆粒
|
|
US20250360199A1
(en)
|
2022-07-07 |
2025-11-27 |
The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services |
Immunogens and methods for inducing an immune response
|
|
EP4562163A1
(en)
|
2022-07-26 |
2025-06-04 |
ModernaTX, Inc. |
Engineered polynucleotides for temporal control of expression
|
|
WO2024044147A1
(en)
|
2022-08-23 |
2024-02-29 |
Modernatx, Inc. |
Methods for purification of ionizable lipids
|
|
US20240108545A1
(en)
|
2022-10-03 |
2024-04-04 |
West Pharmaceutical Services, Inc. |
Methods and adapters for mixing pharmaceutical complexes
|
|
WO2024089638A1
(en)
|
2022-10-28 |
2024-05-02 |
Glaxosmithkline Biologicals Sa |
Nucleic acid based vaccine
|
|
WO2024097639A1
(en)
|
2022-10-31 |
2024-05-10 |
Modernatx, Inc. |
Hsa-binding antibodies and binding proteins and uses thereof
|
|
CN115521934A
(zh)
*
|
2022-10-31 |
2022-12-27 |
中国科学院上海高等研究院 |
一种基于胆固醇修饰的脂质立方相核酸结晶方法
|
|
WO2024102730A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and nanoparticle compositions for delivering polynucleotides
|
|
WO2024102762A1
(en)
|
2022-11-08 |
2024-05-16 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
US20260191905A1
(en)
|
2022-12-01 |
2026-07-09 |
Modernatx, Inc. |
Gpc3-specific antibodies, binding domains, and related proteins and uses thereof
|
|
AU2023393613A1
(en)
|
2022-12-12 |
2025-06-19 |
Global Life Sciences Solutions Canada Ulc |
Lipid nanoparticles lyophilization methods and compositions
|
|
TW202440929A
(zh)
|
2022-12-14 |
2024-10-16 |
加拿大商普羅維登斯治療控股公司 |
用於感染性疾病的組合物和方法
|
|
EP4634390A2
(en)
|
2022-12-15 |
2025-10-22 |
Orna Therapeutics, Inc. |
Circular rna compositions and methods
|
|
WO2024130158A1
(en)
|
2022-12-16 |
2024-06-20 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding extended serum half-life interleukin-22 for the treatment of metabolic disease
|
|
US20260218178A1
(en)
|
2022-12-22 |
2026-07-30 |
Mina Therapeutics Limited |
Chemically Modified saRNA Compositions and Methods of Use
|
|
WO2024140893A1
(zh)
|
2022-12-29 |
2024-07-04 |
辽宁键凯科技有限公司 |
一种类固醇-阳离子脂质化合物及其应用
|
|
WO2024163918A1
(en)
|
2023-02-02 |
2024-08-08 |
University Of Houston System |
Mrna vaccine for herpes simplex virus
|
|
CN115844833A
(zh)
*
|
2023-02-14 |
2023-03-28 |
武汉载元生物科技有限公司 |
一种可电离脂质纳米粒及其制备方法
|
|
WO2024182301A2
(en)
|
2023-02-27 |
2024-09-06 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding galactose-1-phosphate uridylyltransferase (galt) for the treatment of galactosemia
|
|
CN118946544A
(zh)
|
2023-03-09 |
2024-11-12 |
上海吉量医药工程有限公司 |
可离子化脂质分子及其制备方法和应用
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
WO2024206329A1
(en)
|
2023-03-27 |
2024-10-03 |
Modernatx, Inc. |
Nucleic acid molecules encoding bi-specific secreted engagers and uses thereof
|
|
WO2024206126A1
(en)
|
2023-03-27 |
2024-10-03 |
Modernatx, Inc. |
Cd16-binding antibodies and uses thereof
|
|
KR102631907B1
(ko)
*
|
2023-03-29 |
2024-01-31 |
(주) 멥스젠 |
균일한 나노입자 제조를 위한 미세유체장치
|
|
WO2024205657A2
(en)
|
2023-03-29 |
2024-10-03 |
Orna Therapeutics, Inc. |
Lipids and lipid nanoparticle compositions for delivering polynucleotides
|
|
JP2026512425A
(ja)
|
2023-03-30 |
2026-04-16 |
オーエスイー・イミュノセラピューティクス |
免疫細胞増強分子の発現のための活性化免疫細胞に標的化された脂質ベースのナノ粒子及びその使用
|
|
WO2024200820A1
(en)
|
2023-03-30 |
2024-10-03 |
Ose Immunotherapeutics |
Method of synthesis of targeted lipid nanoparticle and uses thereof
|
|
WO2024227430A1
(zh)
|
2023-04-29 |
2024-11-07 |
康希诺(上海)生物研发有限公司 |
一种类固醇-阳离子脂质化合物及其应用
|
|
EP4721759A1
(en)
|
2023-04-29 |
2026-04-08 |
Cansino (Shanghai) Biological Research Co., Ltd. |
Lipid nanoparticle for delivering nucleic acid drug, and preparation method therefor and use thereof
|
|
EP4704816A1
(en)
|
2023-05-03 |
2026-03-11 |
ModernaTX, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2024243053A1
(en)
*
|
2023-05-19 |
2024-11-28 |
The Trustees Of The University Of Pennsylvania |
Fouling resistant microfluidic mixing device for robust manufacturing of nanoparticles
|
|
KR20260030139A
(ko)
|
2023-06-28 |
2026-03-05 |
글로벌 라이프 사이언시즈 솔루션즈 캐나다 유엘씨 |
세포 요법을 위한 지질 나노입자 제형 및 관련 방법
|
|
WO2025006385A1
(en)
|
2023-06-30 |
2025-01-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Novel malaria vaccine comprising ama1 and ron2 antigens
|
|
CN121866069A
(zh)
|
2023-08-03 |
2026-04-14 |
宾夕法尼亚大学理事会 |
编码单纯疱疹病毒糖蛋白e和/或糖蛋白i抗原的rna组合物及其用途
|
|
AU2024316992A1
(en)
|
2023-08-03 |
2026-03-12 |
BioNTech SE |
Rna compositions encoding herpes simplex virus glycoprotein b antigens and uses thereof
|
|
WO2025042806A2
(en)
|
2023-08-21 |
2025-02-27 |
Modernatx, Inc. |
C-met binding antibodies, nucleic acids encoding same, and methods of use
|
|
WO2025049690A1
(en)
|
2023-08-29 |
2025-03-06 |
Orna Therapeutics, Inc. |
Circular polyethylene glycol lipids
|
|
WO2025049579A1
(en)
|
2023-08-31 |
2025-03-06 |
Global Life Sciences Solutions Canada Ulc |
Intranasal formulation for pulmonary delivery of nanoparticles, compositions, uses, and manufacturing methods thereof
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
WO2025117969A1
(en)
|
2023-12-01 |
2025-06-05 |
Orna Therapeutics, Inc. |
Process for manufacturing lipid nanoparticles
|
|
WO2025133115A1
(en)
|
2023-12-21 |
2025-06-26 |
Ose Immunotherapeutics |
Lipid-based nanoparticles comprising il-35
|
|
WO2025166238A1
(en)
|
2024-01-31 |
2025-08-07 |
Orna Therapeutics, Inc. |
Fast-shedding polyethylene glycol lipids
|
|
TW202543583A
(zh)
|
2024-03-01 |
2025-11-16 |
加拿大商阿奎特斯醫療公司 |
用於將治療劑包覆於脂質奈米顆粒中之材料及方法
|
|
CN118001254B
(zh)
|
2024-04-09 |
2024-07-26 |
北京悦康科创医药科技股份有限公司 |
靶向抗原呈递细胞的脂质组合物及其应用
|
|
WO2025219528A1
(en)
|
2024-04-17 |
2025-10-23 |
Global Life Sciences Solutions Canada Ulc |
Non-destructive plasmid delivery to immune cells
|
|
WO2025219491A1
(en)
|
2024-04-17 |
2025-10-23 |
Global Life Sciences Solutions Canada Ulc |
Method and composition for hdr template dna delivery
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|
|
WO2025255393A1
(en)
|
2024-06-06 |
2025-12-11 |
The Trustees Of The University Of Pennsylvania |
Herpes simplex virus antigen binding agents for mitigation of herpes simplex virus associated disease
|
|
WO2026012450A1
(zh)
*
|
2024-07-11 |
2026-01-15 |
石药集团中奇制药技术(石家庄)有限公司 |
一种非病毒载体介导的大片段dna定点敲入系统
|
|
WO2026018213A1
(en)
|
2024-07-18 |
2026-01-22 |
Vaxthera Sas |
A broadly protective mosaic vaccine against highly pathogenic avian influenza viruses
|
|
WO2026027887A2
(en)
|
2024-08-02 |
2026-02-05 |
Mina Therapeutics Limited |
Hbg1/2-sarna compositions and methods of use
|
|
WO2026035687A1
(en)
|
2024-08-05 |
2026-02-12 |
University Of Rochester |
Compositions and methods for stitchr-mediated full-length scn5a expression in vivo
|
|
US20260124157A1
(en)
|
2024-08-09 |
2026-05-07 |
Genvax Technologies, Inc. |
Methods of self-amplifying rna-lipid nanoparticle manufacture and compositions derived therefrom
|
|
WO2026044055A1
(en)
|
2024-08-23 |
2026-02-26 |
Modernatx, Inc. |
Muc16 binding molecules, nucleic acids encoding same, and methods of use
|
|
WO2026068705A1
(en)
|
2024-09-26 |
2026-04-02 |
Ose Immunotherapeutics |
Lipid-based nanoparticles comprising non-glycosylated fc domains and uses thereof
|
|
WO2026075820A1
(en)
|
2024-10-03 |
2026-04-09 |
Modernatx, Inc. |
4-1bb binding molecules, nucleic acids encoding same, and methods of use
|
|
WO2026093414A1
(en)
|
2024-10-30 |
2026-05-07 |
Ose Immunotherapeutics |
Lipid-based nanoparticles comprising membrane il-35
|
|
WO2026102245A1
(en)
*
|
2024-11-07 |
2026-05-15 |
The Trustees Of The University Of Pennsylvania |
Microfluidic mixing devices for high-throughput lipid nanoparticle (lnp) preparation
|
|
WO2026112050A2
(en)
|
2024-11-21 |
2026-05-28 |
Modernatx, Inc. |
Claudin 6 binding molecules, nucleic acids encoding same, and methods of use
|
|
WO2026119908A1
(en)
|
2024-12-05 |
2026-06-11 |
Merck Patent Gmbh |
Helper lipids in nucleic acid delivery
|
|
WO2026122882A2
(en)
|
2024-12-06 |
2026-06-11 |
Modernatx, Inc. |
Solid tumor t cell engagers and uses thereof
|
|
WO2026151698A1
(en)
|
2025-01-07 |
2026-07-16 |
Modernatx, Inc. |
Lag3 binding molecules, nucleic acids encoding same, and methods of use
|
|
WO2026155976A1
(en)
|
2025-01-14 |
2026-07-23 |
Modernatx, Inc. |
Pd-1 binding proteins, nucleic acids encoding same, and methods of use
|
|
WO2026165530A1
(en)
|
2025-02-03 |
2026-08-06 |
Renagade Therapeutics Management Inc. |
Hydrophilic polymer lipids for use in lipid nanoparticles
|